Yingying Fei

发表

Hsa-circ_0003420 induces apoptosis in acute myeloid leukemia stem cells and impairs stem cell properties

Yanming Zhang, G. Lin, Yingying Fei, 2021, Immunopharmacology and immunotoxicology.

Glucagon-like peptide-1 loaded phospholipid micelles for the treatment of type 2 diabetes: improved pharmacokinetic behaviours and prolonged glucose-lowering effects

Junjie Fu, Yan Tang, Xiaoke Gu, 2016 .

Lithocholic Acid-Based Peptide Delivery System for an Enhanced Pharmacological and Pharmacokinetic Profile of Xenopus GLP-1 Analogs.

Jing Han, Junjie Fu, Xinyu Chen, 2018, Molecular pharmaceutics.

Regioselective Dechloroacetylations Mediated by Ammonium Acetate: Practical Syntheses of 2,3,4,6‐Tetra‐ O ‐chloroacetyl‐glycopyranoses and Cinnamoyl Glucose Esters

Zhihong Xu, Penghua Shu, Zhi-yu Ju, 2020, ChemistrySelect.

Angelicosides I-IV, four undescribed furanocoumarin glycosides from Angelica dahurica roots and their tyrosinase inhibitory activities

Zhihong Xu, Fugang Xiao, Penghua Shu, 2020 .

Isolation, structure elucidation, tyrosinase inhibitory, and antioxidant evaluation of the constituents from Angelica dahurica roots

Zhihong Xu, Penghua Shu, Zhi-yu Ju, 2019, Journal of Natural Medicines.

Secondary Metabolites with Tyrosinase and Acetylcholinesterase Inhibitory Activities from Leonuri Fructus

Fugang Xiao, Penghua Shu, Ting Xu, 2021, Records of Natural Products.

Two new phenylethanoid glycosides from Ginkgo biloba leaves and their tyrosinase inhibitory activities.

Zhihong Xu, Fugang Xiao, Penghua Shu, 2020, Carbohydrate research.

Isolation and characterization of bioactive phenolic compounds from Cinnamomum camphora barks

Penghua Shu, Ting Xu, Yingying Fei, 2022, Holzforschung.

Micellar Nanomedicine of Novel Fatty Acid Modified Xenopus Glucagon-like Peptide-1: Improved Physicochemical Characteristics and Therapeutic Utilities for Type 2 Diabetes.

Jing Han, Junjie Fu, Xinyu Chen, 2017, Molecular pharmaceutics.

Association between miR-212-3p and SOX11, and the effects of miR-212-3p on cell proliferation and migration in mantle cell lymphoma

Yanming Zhang, G. Lin, Yingying Fei, 2021, Oncology letters.

Xenopus‐derived glucagon‐like peptide‐1 and polyethylene‐glycosylated glucagon‐like peptide‐1 receptor agonists: long‐acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities

Jing Han, Junjie Fu, Xinyu Chen, 2017, British journal of pharmacology.

Xenopus GLP‐1‐inspired discovery of novel GLP‐1 receptor agonists as long‐acting hypoglycemic and insulinotropic agents with significant therapeutic potential

Jing Han, Junjie Fu, Xinyu Chen, 2017, Biochemical pharmacology.

The chronic administration of two novel long‐acting Xenopus glucagon‐like peptide‐1 analogs xGLP159 and XGLP296 potently improved systemic metabolism and glycemic control in rodent models

Tingting Meng, Jing Han, Junjie Fu, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents.

Yue Huang, Jing Han, Junjie Fu, 2018, European journal of medicinal chemistry.

Lipidation and conformational constraining for prolonging the effects of peptides: Xenopus glucagon‐like peptide 1 analogues with potent and long‐acting hypoglycemic activity

Yue Huang, Jing Han, Junjie Fu, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Design, synthesis and biological evaluation of PEGylated Xenopus glucagon-like peptide-1 derivatives as long-acting hypoglycemic agents.

Jing Han, Junjie Fu, Yingying Fei, 2017, European journal of medicinal chemistry.